Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situA twist for survival and cancer progressionIn breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherinIonizing radiation induces heritable disruption of epithelial cell interactionsThe E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.Claudin 1 in Breast Cancer: New InsightsCorrelation of immunoglobulin G expression and histological subtype and stage in breast cancerHost genetics and tumour metastasis.Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.Modeling the competition between lung metastases and the immune system using agents.Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancerDisruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptorEpithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancerIncreased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination.Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progressionBromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.E-Cadherin as a diagnostic biomarker in breast cancer.Cadherin cell adhesion system in canine mammary cancer: a review.Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEMA prognostic index for operable, node-negative breast cancer.Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian originReal time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis.P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.No evidence of familial correlation in breast cancer metastasisSilibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice.Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.Biomarkers for EMT and MET in breast cancer: An update.Significance of E-cadherin expression in triple-negative breast cancer.Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resectionCollective cell migration over long time scales reveals distinct phenotypes.
P2860
Q21195234-C7E30C3B-2588-459F-AE65-CDC92954C8E8Q24652500-F6940A2C-1BF7-47C3-ADC2-B420DD3142CBQ24653604-5EA26D47-B6FD-4EA6-ABE6-31401EAC458EQ24685810-61C326EC-3997-471B-97B3-D5983C68AF00Q24801633-C78B0A26-76AB-470F-B30B-DA670ACE9C6AQ26774988-403F17E7-3E73-47A2-930B-7D809B1F474EQ28703880-38142CCC-3B92-41CA-B07F-61723106CECCQ33198388-F5A31399-CEB0-429E-A23C-B68E97414091Q33222808-F2BCBDA3-C490-46B0-A7D6-1350889EE334Q33755575-E7957884-0030-485A-A67F-71A7289C1B3EQ33759086-72D6BC9A-3E7B-43FB-A10E-CD765B0A6006Q34433806-607852E9-CA92-4CD6-ABF8-B2DFF763756BQ34762639-4261918B-8688-4757-82CF-44CEDCA37AE5Q34978807-7820011F-539A-4BB5-B7DC-E510A109D72AQ35095237-FEE57789-D8AD-4168-A8F5-AF09B5C1A61AQ35223897-65E738E1-DC9B-452B-A799-073F3B4E9872Q35586063-E92DA6B1-CB5C-4EA9-AFF0-DB7D80E9C8E5Q35636561-51584972-2C66-48A5-91CD-89D8AC39E20DQ35684573-856C36CF-C21F-41C5-9AA1-724D85FA4168Q35889626-7012D23B-BDCE-441A-B2C4-58520FE130E9Q35915812-0F1BC5E7-4E2C-4C6E-9A88-BB0BAFA8176EQ36204016-E438E459-F51B-493C-B605-2A15EE75291EQ36266501-DD406E3D-BE8A-4733-AAC1-4E9C2533463DQ36283722-618932A3-B666-47EB-AC73-6A73730B99FFQ36694138-6C3CC1F2-4D04-4A59-BDA2-ABD04E026E95Q36696681-1D71BC92-EFF0-4C0B-98E6-D536764A3A52Q36728786-0DC2EE76-4CD2-4862-BB9B-6006C94F43CAQ36763984-8EFA4E82-862D-4EA7-AA31-7791A19CDABEQ37170854-7EAFC467-4BB4-4BFE-AB08-1CB9ED8AFCD5Q37438439-9CD70071-012A-4F94-B3CB-69C8BEF2595AQ37618125-68A7E863-C15B-487D-A048-5250B0AA93E4Q37697134-9F982271-8A31-45DF-89AB-2D6894C3E183Q38293605-82417AD9-7914-42D5-BBA9-04ED03716E42Q39095878-71F48FEC-96DB-4BFE-9FB1-AC17411FF9A8Q41853957-74F4A305-86F3-4F5B-A8D3-E982B9121265Q41920880-7DEE9F0F-F001-4A23-AE8E-B7D86979D6DFQ55025058-CD981DBB-DC49-4C41-927A-C75CA1206B4A
P2860
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Separating favorable from unfa ...... ancer: the role of E-cadherin.
@en
type
label
Separating favorable from unfa ...... ancer: the role of E-cadherin.
@en
prefLabel
Separating favorable from unfa ...... ancer: the role of E-cadherin.
@en
P2093
P1433
P1476
Separating favorable from unfa ...... ancer: the role of E-cadherin.
@en
P2093
P304
P407
P577
2000-01-01T00:00:00Z